Adhesion Barriers Market

Market Insights

Adhesion barriers are used for reducing internal scarring and separating the internal organs and tissues, therefore avoiding organ adhesion. These products are predominantly employed in abdominal, orthopedic, reconstructive, urological, and gynecological surgeries. Of the various formulations available, adhesion barriers based on the film are the most widely used. As the global rate of surgical procedures is consistently increasing, the demand for and uptake of adhesion barriers are also expected to rise correspondingly. Adhesion barriers are viewed as an effective tool to reduce the post-surgical complications arising from the adhesion of tissues or organs, therefore reducing the risk of follow-up procedures and the overall procedural cost. Growing product visibility and competitive prices of adhesion barriers are also expected to assist the market’s growth during the forecast period.

Apart from the increasing number of abdominal and cardiovascular interventions taking place worldwide, the growing incidence of cancers demanding surgical intervention is also driving the demand for adhesion barriers. Growing awareness of the benefits of adhesion barriers in lowering treatment costs will be a primary driver in developing countries. Further expansion in application areas of these products and product universality across several anatomies will serve as significant growth opportunities during and beyond the forecast period.

Market Synopsis

Synthetic Adhesion Barriers to Enjoy the Dominant Market Position

At present, over half of the market for adhesion barriers is occupied by synthetic barrier products. A greater presence in the market is a key attribute of the dominance of this segment. Additionally, the cost-effectiveness of synthetic adhesion barriers is better than that of natural product variants. This segment is further categorized as hyaluronic acid, polyethylene glycol (PEG), regenerated cellulose, and other synthetic products. Among these, the demand for PEG-based adhesion barriers is anticipated to be the fastest during the forecast period. Its better biocompatibility and absorption capabilities support the high demand.

Based on formulation types, the global market for adhesion barriers is segmented into gels, liquids, and films. Films occupy a significant share of the global market. Higher adoption of film and mesh in postoperative procedures, particularly in gynecology and abdominal surgeries, is attributed to the prominent position of the film’s segment. Gel formulations will progress at a faster rate during the forecast period. These formulations are sterile, highly viscous, and transparent, making them better barriers to prevent adhesions. Liquid barriers are made of glucose polymers and are used to prevent tissue adhesion during and after surgery. Adept and Bio-Gide Perio are the most commonly used liquid barriers.

Gynecological Procedures to Spearhead the Global Market

On the basis of applications, the global adhesion barriers market is segmented into gynecology, general abdominal surgery, cardiovascular, neurology, orthopedics, urology, and others. Among these, gynecological surgery applications have the largest revenue share in the global market. The increasing volume of C-section surgeries, hysterectomies and the increasing prevalence of uterine cancers drive the dominance of this segment. In laparoscopic gynecological surgeries, the adoption of film and gel-based adhesion barriers is the highest.

Asia Pacific is estimated to be the fastest-progressing regional market.

Large procedural rates of surgical interventions, swift approval of novel products, and favorable reimbursements are the major factors that have made North America the largest regional market for adhesion barriers. North America accounts for approximately 34% of the global market share and is followed by Europe. The dominance of several major market players also supports the dominant position of North America and Europe. Asia Pacific is the fastest-growing regional market for adhesion barriers. A major factor supporting the rapid growth of the Asia-Pacific market is growing awareness about the benefits associated with adhesion barriers in general surgeries in terms of reducing the rate of follow-up surgeries for eradicating adhesion complications. The growing number of surgeries in the region as a result of the rapidly growing pool of chronic diseases and geriatric population, as well as flourishing medical tourism, are some of the other major factors driving the growth of the Asia-Pacific market.

Periods of History and Forecast

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The adhesion barriers market report provides a quantitative assessment of the industry in terms of current and forecasted market size while also presenting the market dynamics. This market is segmented based on device type, formulation, surgical application, and geography.

Along with the market size and forecast, this report also includes a qualitative analysis of each of the considered segments in terms of the prevailing trends and future outlook for such segments. This report also includes an exclusive section analyzing market dynamics such as challenges, restraints, and opportunities. In the same section of the study, the market competition landscape and appealing investment propositions are also presented. Moreover, this report also includes a brief profile of the major market players, namely Johnson & Johnson, Anika Therapeutics, C. R. Bard, Inc., FzioMed, Baxter International, Sanofi-Aventis U.S. LLC, W. L. Gore & Associates, MAST Biosurgery, Inc., Integra LifeSciences Holdings Corporation, Becton Dickinson and Company, and Atrium Medical Corporation. This profiling is made based on parameters such as company overview, product portfolio, financial information, and key developments.

Key questions are answered in this report.

• What are the most lucrative opportunities for growth in the global market for adhesion barriers?
• Which type of barrier formulation is in the highest demand globally?
• Which surgical application is anticipated to witness the fastest market growth during the forecast period?
• Will the demand for natural barriers surpass the incumbent position of the synthetic barriers segment?
• Who are the major players in the global market for adhesion barriers?
• What are the key strategies adopted by such players to retain their market position?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global AB Market Portraiture
2.2. Global AB Market, by Product Type, 2017 (US$ Mn)
2.3. Global AB Market, by Formulation, 2017 (US$ Mn)
2.4. Global AB Market, by Surgical Application, 2017 (US$ Mn)
2.5. Global AB Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Adhesion Barriers (AB) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global AB Market, by Key Players, 2017

Chapter 4. Global Adhesion Barriers (AB) Market, by Product Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Synthetic Barriers
4.2.1. Hyaluronic Acid
4.2.2. Polyethylene Glycol (PEG)
4.2.3. Regenerated Cellulose
4.2.4. Others
4.3. Natural Barriers
4.3.1. Fibrin
4.3.2. Collagen & Protein

Chapter 5. Global Adhesion Barriers (AB) Market, by Formulation, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Gel
5.3. Liquid
5.4. Film

Chapter 6. Global Adhesion Barriers (AB) Market, by Surgical Application, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. Gynecology
6.3. Abdominal General Surgery
6.4. Cardiovascular
6.5. Neurology
6.6. Orthopedic
6.7. Urology
6.8. Others

Chapter 7. Global Adhesion Barriers (AB) Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.2. North America AB Market, 2016 – 2026 (US$ Mn)
7.2.1. North America AB Market, by Product Type, 2016 – 2026 (US$ Mn)
7.2.2. North America AB Market, by Formulation, 2016 – 2026 (US$ Mn)
7.2.3. North America AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
7.2.4. North America AB Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe AB Market, 2016 – 2026 (US$ Mn)
7.3.1. Europe AB Market, by Product Type, 2016 – 2026 (US$ Mn)
7.3.2. Europe AB Market, by Formulation, 2016 – 2026 (US$ Mn)
7.3.3. Europe AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
7.3.4. Europe AB Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific AB Market, 2016 – 2026 (US$ Mn)
7.4.1. Asia Pacific AB Market, by Product Type, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific AB Market, by Formulation, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific AB Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America AB Market, 2016 – 2026 (US$ Mn)
7.5.1. Latin America AB Market, by Product Type, 2016 – 2026 (US$ Mn)
7.5.2. Latin America AB Market, by Formulation, 2016 – 2026 (US$ Mn)
7.5.3. Latin America AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
7.5.4. Latin America AB Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa AB Market, 2016 – 2026 (US$ Mn)
7.6.1. Middle East & Africa AB Market, by Product Type, 2016 – 2026 (US$ Mn)
7.6.2. Middle East & Africa AB Market, by Formulation, 2016 – 2026 (US$ Mn)
7.6.3. Middle East & Africa AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
7.6.4. Middle East & Africa AB Market, by Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of Middle East & Africa

Chapter 8. Company Profiles
8.1. Johnson & Johnson
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Anika Therapeutics
8.3. C. R. Bard, Inc.
8.4. FzioMed
8.5. Baxter International
8.6. Sanofi-Aventis U.S. LLC
8.7. W. L. Gore & Associates
8.8. MAST Biosurgery, Inc.
8.9. Integra LifeSciences Holdings Corporation
8.10. Becton Dickinson and Company
8.11. Atrium Medical Corporation

List of Figures

FIG 1. Adhesion Barriers (AB) Market: Research Methodology
FIG 2. Market Size Estimation – Top Down & Bottom up Approach
FIG 3. Adhesion Barriers: Market Segmentation
FIG 4. Global AB Market, by Product Type, 2017 (US$ Mn)
FIG 5. Global AB Market, by Formulation, 2017 (US$ Mn)
FIG 6. Global AB Market, by Geography, 2017 (US$ Mn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global AB Market, by Key Players, 2017
FIG 9. Global Hyaluronic Acid AB Market, 2016 – 2026 (US$ Mn)
FIG 10. Global Polyethylene Glycol (PEG) AB Market, 2016 – 2026 (US$ Mn)
FIG 11. Global Regenerated Cellulose AB Market, 2016 – 2026 (US$ Mn)
FIG 12. Global Other Synthetic AB Market, 2016 – 2026 (US$ Mn)
FIG 13. Global Fibrin AB Market, 2016 – 2026 (US$ Mn)
FIG 14. Global Collagen and Protein AB Market, 2016 – 2026 (US$ Mn)
FIG 15. Global Gel AB Market, 2016 – 2026 (US$ Mn)
FIG 16. Global Liquid AB Market, 2016 – 2026 (US$ Mn)
FIG 17. Global Film AB Market, 2016 – 2026 (US$ Mn)
FIG 18. Global AB Market for Gynecology, 2016 – 2026 (US$ Mn)
FIG 19. Global AB Market for Abdominal General Surgery, 2016 – 2026 (US$ Mn)
FIG 20. Global AB Market for Cardiovascular, 2016 – 2026 (US$ Mn)
FIG 21. Global AB Market for Neurology, 2016 – 2026 (US$ Mn)
FIG 22. Global AB Market for Orthopedics, 2016 – 2026 (US$ Mn)
FIG 23. Global AB Market for Urology, 2016 – 2026 (US$ Mn)
FIG 24. Global AB Market for Other Surgical Applications, 2016 – 2026 (US$ Mn)
FIG 25. U.S. AB Market, 2016 – 2026 (US$ Mn)
FIG 26. Canada AB Market, 2016 – 2026 (US$ Mn)
FIG 27. U.K. AB Market, 2016 – 2026 (US$ Mn)
FIG 28. Germany AB Market, 2016 – 2026 (US$ Mn)
FIG 29. Rest of Europe AB Market, 2016 – 2026 (US$ Mn)
FIG 30. China AB Market, 2016 – 2026 (US$ Mn)
FIG 31. Japan AB Market, 2016 – 2026 (US$ Mn)
FIG 32. India AB Market, 2016 – 2026 (US$ Mn)
FIG 33. Rest of Asia Pacific AB Market, 2016 – 2026 (US$ Mn)
FIG 34. Brazil AB Market, 2016 – 2026 (US$ Mn)
FIG 35. Mexico AB Market, 2016 – 2026 (US$ Mn)
FIG 36. Rest of Latin America AB Market, 2016 – 2026 (US$ Mn)
FIG 37. GCC AB Market, 2016 – 2026 (US$ Mn)
FIG 38. Rest of Middle East and Africa AB Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Adhesion Barriers (AB) Market Portraiture
TABLE 2 Global AB Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Synthetic AB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Natural AB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global AB Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 6 Global AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 7 Global AB Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 8 North America AB Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 9 North America AB Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 10 North America AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 11 North America AB Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Europe AB Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 13 Europe AB Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 14 Europe AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 15 Europe AB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific AB Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific AB Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 18 Asia Pacific AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 19 Asia Pacific AB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Latin America AB Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America AB Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 22 Latin America AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 23 Latin America AB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 24 Middle East and Africa AB Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa AB Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 26 Middle East and Africa AB Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 27 Middle East and Africa AB Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 28 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Anika Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 C. R. Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 FzioMed: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Baxter International: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Sanofi-Aventis U.S. LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 W. L. Gore & Associates: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 MAST Biosurgery, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 Integra LifeSciences Holdings Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 38 Atrium Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)